Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Warren

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Trends in Pharmacological Sciences|September 19, 2009
Precaution, cyclooxygenase inhibition, and cardiovascular riskJames M Ritter, Idris Harding, John B Warren
British Journal of Clinical Pharmacology|February 3, 2018
The pharmacodynamic and clinical trial evidence for statin doseSimon B Dimmitt, Hans G Stampfer, John B Warren
British Journal of Clinical Pharmacology|June 11, 2014
β-adrenoceptor blockers valuable but higher doses not necessarySimon B Dimmitt, Hans G Stampfer, John B Warren
Journal of the American College of Cardiology|August 15, 2020
Small Increase in Mortality With High Dose, But Not Low Dose, StatinSimon B Dimmitt, John B Warren, Hans G Stampfer
British Journal of Clinical Pharmacology|April 5, 2016
Cholesterol trials and mortalityJohn B Warren, Simon B Dimmitt, Hans G Stampfer
British Journal of Clinical Pharmacology|January 24, 2015
Common statin side effects explain poor complianceSimon B Dimmitt, Hans G Stampfer, John B Warren
Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada|July 20, 2007
High resolution FESEM and TEM reveal bacterial spore attachmentBarbara J Panessa-Warren, George T Tortora, John B Warren
Journal of the American College of Cardiology|September 17, 2016
Trading Lower HbA1c for Increased Adverse Events: A Zero Sum Game?Simon B Dimmitt, John B Warren, Jennifer H Martin, et al.
Lancet (London, England)|March 15, 2018
Clinical benefits of evolocumab appear less than hopedSimon B Dimmitt, Hans G Stampfer, Jennifer H Martin, et al.
Journal of the American College of Cardiology|October 13, 2022
High-Dose Statins Increase Adverse Events and Do Not Improve SurvivalSimon B Dimmitt, Hans G Stampfer, John B Warren, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Trends in Pharmacological Sciences|September 19, 2009
Precaution, cyclooxygenase inhibition, and cardiovascular riskJames M Ritter, Idris Harding, John B Warren
British Journal of Clinical Pharmacology|February 3, 2018
The pharmacodynamic and clinical trial evidence for statin doseSimon B Dimmitt, Hans G Stampfer, John B Warren
British Journal of Clinical Pharmacology|June 11, 2014
β-adrenoceptor blockers valuable but higher doses not necessarySimon B Dimmitt, Hans G Stampfer, John B Warren
Journal of the American College of Cardiology|August 15, 2020
Small Increase in Mortality With High Dose, But Not Low Dose, StatinSimon B Dimmitt, John B Warren, Hans G Stampfer
British Journal of Clinical Pharmacology|April 5, 2016
Cholesterol trials and mortalityJohn B Warren, Simon B Dimmitt, Hans G Stampfer
British Journal of Clinical Pharmacology|January 24, 2015
Common statin side effects explain poor complianceSimon B Dimmitt, Hans G Stampfer, John B Warren
Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada|July 20, 2007
High resolution FESEM and TEM reveal bacterial spore attachmentBarbara J Panessa-Warren, George T Tortora, John B Warren
Journal of the American College of Cardiology|September 17, 2016
Trading Lower HbA1c for Increased Adverse Events: A Zero Sum Game?Simon B Dimmitt, John B Warren, Jennifer H Martin, et al.
Lancet (London, England)|March 15, 2018
Clinical benefits of evolocumab appear less than hopedSimon B Dimmitt, Hans G Stampfer, Jennifer H Martin, et al.
Journal of the American College of Cardiology|October 13, 2022
High-Dose Statins Increase Adverse Events and Do Not Improve SurvivalSimon B Dimmitt, Hans G Stampfer, John B Warren, et al.
Pageof 3